A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Medically reviewed by Elizabeth Barnes, RDN Berberine is a natural compound in flowering plants like barberry, coptis root, ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk ... area because it has a different mode of action than the existing standard of care (SOC) in ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients ...

Ozempic is also approved to reduce the risk ... an unmet need in the kidney disease space as it has an alternate mechanism of action to current standard of care (SOC) in CKD, says GlobalData ...

Ozempic, the blockbuster GLP-1 drug that was ... But even though scientists don't fully understand the mechanisms behind them, the positive effects are strong: The clinical study was stopped ...